BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2437548)

  • 1. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
    Munekata E; Kubo K; Tanaka H; Osakada F
    Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of novel mammalian tachykinins, neurokinin alpha and neurokinin beta.
    Kimura S; Goto K; Ogawa T; Sugita Y; Kanazawa I
    Neurosci Res; 1984 Dec; 2(1-2):97-104. PubMed ID: 6085651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contractile activities of neurokinin A, B and related peptides on smooth muscles.
    Osakada F; Kubo K; Goto K; Kanazawa I; Munekata E
    Eur J Pharmacol; 1986 Jan; 120(2):201-8. PubMed ID: 2419146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
    Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
    Hall JM; Morton IK
    Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
    Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
    Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of neurokinin A and B COOH-terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes.
    Kodama H; Shimohigashi Y; Sakaguchi K; Waki M; Takano Y; Yamada A; Hatae Y; Kamiya H
    Eur J Pharmacol; 1988 Jul; 151(2):317-20. PubMed ID: 2844557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin antagonist I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.
    Hashimoto T; Uchida Y; Naminohira S; Sakai T
    Jpn J Pharmacol; 1987 Dec; 45(4):570-3. PubMed ID: 3481842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies of tachykinin receptors mediating contraction of isolated airway smooth muscle.
    Buckner CK; Ghanekar SV; Kays JS; Krell RD; Fishleder RI; Will JA; Vann JM
    Ann N Y Acad Sci; 1991; 629():340-58. PubMed ID: 1719852
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent and highly selective neurokinin antagonists.
    Ward P; Ewan GB; Jordan CC; Ireland SJ; Hagan RM; Brown JR
    J Med Chem; 1990 Jul; 33(7):1848-51. PubMed ID: 1694545
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro actions of mammalian tachykinins.
    Holzer-Petsche U; Schimek E; Amann R; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tachykinin receptors in isolated basilar arteries of guinea-pig.
    Edvinsson L; Jansen I
    Br J Pharmacol; 1987 Mar; 90(3):553-9. PubMed ID: 2436702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presence of a septide-sensitive tachykinin receptor in the circular muscle of the guinea-pig ileum.
    Maggi CA; Patacchini R; Meini S; Giuliani S
    Eur J Pharmacol; 1993 Apr; 235(2-3):309-11. PubMed ID: 7685292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly selective agonists for substance P receptor subtypes.
    Wormser U; Laufer R; Hart Y; Chorev M; Gilon C; Selinger Z
    EMBO J; 1986 Nov; 5(11):2805-8. PubMed ID: 2431898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
    Grandordy BM; Frossard N; Rhoden KJ; Barnes PJ
    Mol Pharmacol; 1988 May; 33(5):515-9. PubMed ID: 2452969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for neurokinin-3 receptor-mediated tachykinin release in the guinea-pig ileum.
    Guard S; Watson SP
    Eur J Pharmacol; 1987 Dec; 144(3):409-12. PubMed ID: 2450037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.